BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Johnson MS, Smith DL Jr, Li Y, Kesterson RA, Allison DB, Nagy TR. Effects of risperidone on energy balance in female C57BL/6J mice. Obesity (Silver Spring) 2013;21:1850-7. [PMID: 23408466 DOI: 10.1002/oby.20350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Jiang HY, Pan LY, Zhang X, Zhang Z, Zhou YY, Ruan B. Altered gut bacterial-fungal interkingdom networks in patients with current depressive episode. Brain Behav 2020;10:e01677. [PMID: 32533650 DOI: 10.1002/brb3.1677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li L, Yoo ES, Li X, Wyler SC, Chen X, Wan R, Arnold AG, Birnbaum SG, Jia L, Sohn JW, Liu C. The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain. J Exp Med 2021;218:e20202484. [PMID: 33978701 DOI: 10.1084/jem.20202484] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Beauchemin M, Geguchadze R, Guntur AR, Nevola K, Le PT, Barlow D, Rue M, Vary CPH, Lary CW, Motyl KJ, Houseknecht KL. Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice. Pharmacol Res 2020;152:104589. [PMID: 31874253 DOI: 10.1016/j.phrs.2019.104589] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
4 Monda V, Salerno M, Sessa F, Bernardini R, Valenzano A, Marsala G, Zammit C, Avola R, Carotenuto M, Messina G, Messina A. Functional Changes of Orexinergic Reaction to Psychoactive Substances. Mol Neurobiol 2018;55:6362-8. [PMID: 29307079 DOI: 10.1007/s12035-017-0865-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
5 Bahr SM, Weidemann BJ, Castro AN, Walsh JW, deLeon O, Burnett CM, Pearson NA, Murry DJ, Grobe JL, Kirby JR. Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. EBioMedicine 2015;2:1725-34. [PMID: 26870798 DOI: 10.1016/j.ebiom.2015.10.018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 11.7] [Reference Citation Analysis]
6 Motyl KJ, DeMambro VE, Barlow D, Olshan D, Nagano K, Baron R, Rosen CJ, Houseknecht KL. Propranolol Attenuates Risperidone-Induced Trabecular Bone Loss in Female Mice. Endocrinology 2015;156:2374-83. [PMID: 25853667 DOI: 10.1210/en.2015-1099] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
7 Fu Y, Yang K, Huang Y, Zhang Y, Li S, Li W. Deciphering Risperidone-Induced Lipogenesis by Network Pharmacology and Molecular Validation. Front Psychiatry 2022;13:870742. [DOI: 10.3389/fpsyt.2022.870742] [Reference Citation Analysis]
8 Kim T, He L, Johnson MS, Li Y, Zeng L, Ding Y, Long Q, Moore JF, Sharer JD, Nagy TR, Young ME, Wood PA, Yang Q. Carnitine Palmitoyltransferase 1b Deficiency Protects Mice from Diet-Induced Insulin Resistance. J Diabetes Metab 2014;5:361. [PMID: 25309812 DOI: 10.4172/2155-6156.1000361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 0.4] [Reference Citation Analysis]